Barclays raised the firm’s price target on Cencora to $263 from $242 and keeps an Overweight rating on the shares. The company reported a “clean” fiscal Q1 headline beat and raise, with fiscal 2024 guidance raised by more than the beat, the analyst tells investors in a research note. The firm continues to see multiple sources of upside for the year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on COR:
- Cencora Schedules Fiscal Quarter Results Discussion Webcast
- Cencora price target raised to $247 from $221 at JPMorgan
- Cencora price target raised to $240 from $220 at Argus
- Early notable gainers among liquid option names on January 3rd
- Barclays starts healthcare technology, distribution with Neutral view
